U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07605819) titled 'Pancreatic Cancer Screening Using the Enzeavour Assay in Japan' on May 11.
Brief Summary: This nationwide, multicenter, prospective, single-arm interventional feasibility study evaluates the Enzeavour Pancreatic Cancer assay in routine health checkups and cancer screening in Japan. Approximately 10,000 asymptomatic adults will be enrolled. Participants with an Enzeavour Score above 0.369 will undergo diagnostic work-up as clinically indicated. The primary outcome is pancreatic cancer detection rate within 12 months after the index blood draw, and the secondary outcome is positive predictive value.
Study Start Date: Feb. 04
Study Ty...